G protein-coupled receptor kinase 5 gene polymorphisms are associated with postoperative atrial fibrillation after coronary artery bypass grafting in patients receiving β-blockers

Circulation: Cardiovascular Genetics

Volumn 7, Issue 5, 2014, Pages 625-633

  Kertai, Miklos D ^a,c   Li, Yen Wei ^b   Li, Yi Ju ^a,b   Shah, Svati H ^a   Kraus, William E ^a   Fontes, Manuel L ^a   Stafford Smith, Mark ^a   Newman, Mark F ^a   Podgoreanu, Mihai V ^a   Mathew, Joseph P ^a   Allen, A S ^c   Davis, R D ^c   Fontes, M J ^c   Funk, B ^c   Gaca, J G ^c   Ginsburg, G S ^c   Glower, D D ^c   Goldstein, D B ^c   Hall, R L ^c   Hauser, E ^c   Jones, R ^c   Laskowitz, D T ^c   Li, Y J ^c   Lodge, A J ^c   Milano, C A ^c   Phillips Bute, B ^c   Smith, M P ^c   Smith, P K ^c   Swaminathan, M ^c   Welsby, I J ^c   White, W D ^c   Willard, H F ^c   more..

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE

Author keywords

Atrial fibrillation; Coronary artery bypass; Polymorphism; Single nucleotide

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYTOCHROME P450 2D6; G PROTEIN COUPLED RECEPTOR KINASE 5; GRK5 PROTEIN, HUMAN;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG TRANSFORMATION; FOLLOW UP; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HUMAN; INTRON; MAJOR CLINICAL STUDY; MIDDLE AGED; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; ATRIAL FIBRILLATION; CASE CONTROL STUDY; FEMALE; GENETICS; MALE; ODDS RATIO;

ADRENERGIC BETA-ANTAGONISTS; AGED; ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; COHORT STUDIES; CORONARY ARTERY BYPASS; FEMALE; G-PROTEIN-COUPLED RECEPTOR KINASE 5; GENETIC VARIATION; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTOPERATIVE COMPLICATIONS; SIGNAL TRANSDUCTION;

EID: 84925862602     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.113.000451     Document Type: Article

References (50)

1. Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, Mazer CD, et al; Investigators of the Ischemia Research and Education Foundation; Multicenter Study of Perioperative Ischemia Research Group. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA. 2004;291:1720-1729
2. Borzak S, Tisdale JE, Amin NB, Goldberg AD, Frank D, Padhi ID, et al. Atrial fibrillation after bypass surgery: Does the arrhythmia or the characteristics of the patients prolong hospital stay? Chest. 1998;113:1489-1491
3. Parvez B, Chopra N, Rowan S, Vaglio JC, Muhammad R, Roden DM, et al. A common β1-adrenergic receptor polymorphism predicts favorable response to rate-control therapy in atrial fibrillation. J Am Coll Cardiol. 2012;59:49-56
4. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al; American College of Cardiology Foundation/American Heart Association Task Force. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2011;123:e269-e367
5. Crystal E, Garfinkle MS, Connolly SS, Ginger TT, Sleik K, Yusuf SS. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. Cochrane Database Syst Rev. 2004:CD003611
6. Johnson JA, Cavallari LH, Beitelshees AL, Lewis JP, Shuldiner AR, Roden DM. Pharmacogenomics: Application to the management of cardiovascular disease. Clin Pharmacol Ther. 2011;90:519-531
7. Zhou SF. Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I. Clin Pharmacokinet. 2009;48:689-723
8. Liggett SB, Cresci S, Kelly RJ, Syed FM, Matkovich SJ, Hahn HS, et al. A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure. Nat Med. 2008;14:510-517
9. Johnson JA, Liggett SB. Cardiovascular pharmacogenomics of adrenergic receptor signaling: Clinical implications and future directions. Clin Pharmacol Ther. 2011;89:366-378
10. Rau T, Wuttke H, Michels LM, Werner U, Bergmann K, Kreft M, et al. Impact of the CYP2D6 genotype on the clinical effects of metoprolol: A prospective longitudinal study. Clin Pharmacol Ther. 2009;85: 269-272
11. Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, von Elm E, et al. Strengthening the reporting of genetic association studies (STREGA): An extension of the STROBE Statement. Hum Genet. 2009;125:131-151
12. Lobato RL, White WD, Mathew JP, Newman MF, Smith PK, McCants CB, et al; Duke Perioperative Genetics and Safety Outcomes (PEGASUS) Investigative Team. Thrombomodulin gene variants are associated with increased mortality after coronary artery bypass surgery in replicated analyses. Circulation. 2011;124(11 suppl):S143-S148
13. Shah AA, Craig DM, Sebek JK, Haynes C, Stevens RC, Muehlbauer MJ, et al. Metabolic profiles predict adverse events after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2012;143:873-878
14. Shah SH, Freedman NJ, Zhang L, Crosslin DR, Stone DH, Haynes C, et al. Neuropeptide Y gene polymorphisms confer risk of early-onset atherosclerosis. PLoS Genet. 2009;5:e1000318
15. Voora D, Horton J, Shah SH, Shaw LK, Newby LK. Polymorphisms associated with in vitro aspirin resistance are not associated with clinical outcomes in patients with coronary artery disease who report regular aspirin use. Am Heart J. 2011;162:166-72.e1
16. Mathew JP, Collard CD, Fontes M, Miao Y, Mangano DT. Perioperative statin therapy decreases the risk of atrial fibrillation after cardiac surgery. Anesth Analg. 2009;108:SCA85
17. Marchini J, Howie B, Myers S, McVean G, Donnelly P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet. 2007;39:906-913
18. Wigginton JE, Cutler DJ, Abecasis GR. A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet. 2005;76:887-893
19. Kertai MD, Fontes M, Podgoreanu MV. Pharmacogenomics of β-blockers and statins: Possible implications for perioperative cardiac complications. J Cardiothorac Vasc Anesth. 2012;26:1101-1114
20. Liggett SB. Genetic, molecular, and clinical characterization of adrenergic receptor polymorhisms. In: Perez DM, ed. The Adrenergic Receptors. Totowa, NJ: Humana Press Inc; 2005:339-364
21. Bijl MJ, Visser LE, van Schaik RH, Kors JA, Witteman JC, Hofman A, et al. Genetic variation in the CYP2D6 gene is associated with a lower heart rate and blood pressure in beta-blocker users. Clin Pharmacol Ther. 2009;85:45-50
22. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A. 2003;100:9440-9445
23. Xiao R, Boehnke M. Quantifying and correcting for the winner's curse in genetic association studies. Genet Epidemiol. 2009;33:453-462
24. Gold JI, Martini JS, Hullmann J, Gao E, Chuprun JK, Lee L, et al. Nuclear translocation of cardiac G protein-Coupled Receptor kinase 5 downstream of select Gq-activating hypertrophic ligands is a calmodulin-dependent process. PLoS One. 2013;8:e57324
25. Dorn GW II. Pharmacogenetic profiling in the treatment of heart disease. Transl Res. 2009;154:295-302
26. Sorriento D, Ciccarelli M, Santulli G, Campanile A, Altobelli GG, Cimini V, et al. The G-protein-coupled receptor kinase 5 inhibits NFkappaB transcriptional activity by inducing nuclear accumulation of IkappaB alpha. Proc Natl Acad Sci U S A. 2008;105:17818-17823
27. Gordon JW, Shaw JA, Kirshenbaum LA. Multiple facets of NF-κB in the heart: To be or not to NF-κB. Circ Res. 2011;108:1122-1132
28. Konia MR, Schaefer S, Liu H. Nuclear factor-[kappa]B inhibition provides additional protection against ischaemia/reperfusion injury in delayed sevoflurane preconditioning. Eur J Anaesthesiol. 2009;26: 496-503
29. Gao G, Dudley SC Jr. Redox regulation, NF-kappaB, and atrial fibrillation. Antioxid Redox Signal. 2009;11:2265-2277
30. Cresci S, Kelly RJ, Cappola TP, Diwan A, Dries D, Kardia SL, et al. Clinical and genetic modifiers of long-term survival in heart failure. J Am Coll Cardiol. 2009;54:432-444
31. Lobmeyer MT, Wang L, Zineh I, Turner ST, Gums JG, Chapman AB, et al. Polymorphisms in genes coding for GRK2 and GRK5 and response differences in antihypertensive-treated patients. Pharmacogenet Genomics. 2011;21:42-49
32. Bengtsson K, Melander O, Orho-Melander M, Lindblad U, Ranstam J, Råstam L, et al. Polymorphism in the beta(1)-adrenergic receptor gene and hypertension. Circulation. 2001;104:187-190
33. Johnson JA, Zineh I, Puckett BJ, McGorray SP, Yarandi HN, Pauly DF. Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol. Clin Pharmacol Ther. 2003;74:44-52
34. Liggett SB, Mialet-Perez J, Thaneemit-Chen S, Weber SA, Greene SM, Hodne D, et al. A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure. Proc Natl Acad Sci U S A. 2006;103:11288-11293
35. Bruck H, Leineweber K, Temme T, Weber M, Heusch G, Philipp T, et al. The Arg389Gly beta1-adrenoceptor polymorphism and catecholamine effects on plasma-renin activity. J Am Coll Cardiol. 2005;46: 2111-2115
36. Humma LM, Puckett BJ, Richardson HE, Terra SG, Andrisin TE, Lejeune BL, et al. Effects of beta1-adrenoceptor genetic polymorphisms on resting hemodynamics in patients undergoing diagnostic testing for ischemia. Am J Cardiol. 2001;88:1034-1037
37. Nicoulina S, Shulman V, Shesternya P, Chernova A, Salmina A, Issachenko O, et al. Association of ADRB1 gene polymorphism with atrial fibrillation. Genet Test Mol Biomarkers. 2010;14:249-253
38. Nia AM, Caglayan E, Gassanov N, Zimmermann T, Aslan O, Hellmich M, et al. Beta1-adrenoceptor polymorphism predicts flecainide action in patients with atrial fibrillation. PLoS One. 2010;5:e11421
39. Jeff JM, Donahue BS, Brown-Gentry K, Roden DM, Crawford DC, Stein CM, et al. Genetic variation in the β1-adrenergic receptor is associated with the risk of atrial fibrillation after cardiac surgery. Am Heart J. 2014;167:101-108.e1
40. Wuttke H, Rau T, Heide R, Bergmann K, Böhm M, Weil J, et al. Increased frequency of cytochrome P450 2D6 poor metabolizers among patients with metoprolol-associated adverse effects. Clin Pharmacol Ther. 2002;72:429-437
41. Human Cythochrome P450 (CYP) Allele Nomenclature Committee. http://www.Cypalleles.Ki.Se/cyp2d6.htm. Accessed April 5, 2013
42. Goryachkina K, Burbello A, Boldueva S, Babak S, Bergman U, Bertilsson L. CYP2D6 is a major determinant of metoprolol disposition and effects in hospitalized Russian patients treated for acute myocardial infarction. Eur J Clin Pharmacol. 2008;64:1163-1173
43. Wang D, Poi MJ, Sun X, Gaedigk A, Leeder JS, Sadee W. Common CYP2D6 polymorphisms affecting alternative splicing and transcription: long-range haplotypes with two regulatory variants modulate CYP2D6 activity. Hum Mol Genet. 2014;23:268-278
44. Fux R, Mörike K, Pröhmer AM, Delabar U, Schwab M, Schaeffeler E, et al. Impact of CYP2D6 genotype on adverse effects during treatment with metoprolol: A prospective clinical study. Clin Pharmacol Ther. 2005;78:378-387
45. Batty JA, Hall AS, White HL, Wikstrand J, de Boer RA, van Veldhuisen DJ, et al; MERIT-HF Study Group. An investigation of CYP2D6 genotype and response to metoprolol CR/XL during dose titration in patients with heart failure: A MERIT-HF substudy. Clin Pharmacol Ther. 2014;95:321-330
46. Body SC, Collard CD, Shernan SK, Fox AA, Liu KY, Ritchie MD, et al. Variation in the 4q25 chromosomal locus predicts atrial fibrillation after coronary artery bypass graft surgery. Circ Cardiovasc Genet. 2009;2:499-506
47. Parvez B, Vaglio J, Rowan S, Muhammad R, Kucera G, Stubblefield T, et al. Symptomatic response to antiarrhythmic drug therapy is modulated by a common single nucleotide polymorphism in atrial fibrillation. J Am Coll Cardiol. 2012;60:539-545
48. Lukacova V, Woltosz WS, Bolger MB. Prediction of modified release pharmacokinetics and pharmacodynamics from in vitro, immediate release, and intravenous data. AAPS J. 2009;11:323-334
49. Rho RW. The management of atrial fibrillation after cardiac surgery. Heart. 2009;95:422-429
50. Willer CJ, Li Y, Abecasis GR. METAL: Fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 2010;26:2190-2191.